Marco Huesch
Managing Director and Chief Medical Officer @ Ping An Global Voyager
Hong Kong, Hong Kong
Marco Huesch is a Series C investor at Ping An Global Voyager in Hong Kong focused on Health Care and Dental. Marco Huesch is the Managing Director and Chief Medical Officer of PING AN.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Marco Huesch invests in
Stages Marco Huesch invests in
Countries Marco Huesch invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (100%)
- Dental 1 (50%)
- Medical 1 (50%)
- Biotechnology 1 (50%)
- Health Diagnostics 1 (50%)
Country
- Israel 1 (50%)
- Germany 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
PlusDental
|
PlusDental is a fast-growing Digital Health Startup in the area of digital orthodontics operating from Berlin/Germany.We treat cosmetic cases of malocclusion (teeth straightening) through our innovative treatment approach using clear aligners.We are a fast growing team of business people and dentists/orthodontists aiming atrevolutionising the treatment of aesthetic orthodontics in Europe. Clear aligners are a fast-growing market segment world wide and we want to help more customers to use the benefits of this easy to use and versatile treatment method. We make treatments much more convenient and affordable for our customers through the use and development of cutting-edge technology. | $35.5M / Series C / May 28, 2020 | |
MeMed
|
MeMed Diagnostics is a personalized diagnostics company founded in 2009. They are here to improve patient care, empower physicians, and lower health-care costs through rapid and actionable diagnostics for infectious diseases. Their main focus is preventing antibiotics misuse.Antibiotics are the most prescribed class of drugs worldwide with aglobal market of 25-30 billion $US. Up to 70% of antibiotics are estimated to be prescribed inappropriately, making them the most misused drug class in the world. Antibiotics misuse leads to ineffective treatment, emergence of resistant strains of bacteria, and is estimated to cost healthcare systems worldwide tens of billions of dollars annually. Their platform, the ImmunoDx™, leverages the world’s most accurate diagnostic system for differentiating bacteria from viruses, crafted by nature, the body’s immune system.ImmunoDx™ combines proprietary biomarkers, algorithms, and clinical know-how to identify the source of infection (virus vs bacteria, bacterial spectrum), by decoding the immune system`s differential response to different pathogens. This unique approach enables ImmunoDx™ to address some of the major challenges facing currently available diagnostics for infectious diseases. | $70M / Series C / Sep 21, 2018 |
Co-Investors
Caesarea Medical Electronics
1 deal together
Foxconn Technology Group
1 deal together
HV Capital
1 deal together
Lakestar
1 deal together
Phoenix Financial
1 deal together
About Ping An Global Voyager
Established by Ping An Group, Ping An Global Voyager is a Hong Kong-based investor in growth stage fintech and healthtech companies. Global Voyager typically invests between US$15 million and US$50 million in non-control positions where an affiliation with Ping An has the potential to meaningfully accelerate a target company’s growth. GlobalVoyager has active investments in Europe, Asia and North America.
Ping An Global Voyager Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jonathan Larsen
CEO
|
|||
|
Marco Huesch
Managing Director and Chief Medical Officer
|
|||
Mingzhe Ma
Founder
|
|||
Mingzhe Ma
Founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Marco Huesch invest in?
Marco Huesch invests primarily in Health Care, Dental and Medical startups, most often at Series C stage. Most of the 2 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Marco Huesch?
Public channels for Marco Huesch include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Marco Huesch last invest?
The most recent investment recorded for Marco Huesch closed in May 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
